nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2B6—Thiotepa—urinary bladder cancer	0.234	0.329	CbGbCtD
Brompheniramine—CYP3A4—Thiotepa—urinary bladder cancer	0.0718	0.101	CbGbCtD
Brompheniramine—CYP2B6—Cisplatin—urinary bladder cancer	0.0645	0.0907	CbGbCtD
Brompheniramine—CYP2E1—Etoposide—urinary bladder cancer	0.0642	0.0904	CbGbCtD
Brompheniramine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0575	0.0809	CbGbCtD
Brompheniramine—CYP2C8—Etoposide—urinary bladder cancer	0.048	0.0675	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0432	0.0608	CbGbCtD
Brompheniramine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0401	0.0564	CbGbCtD
Brompheniramine—CYP2C9—Cisplatin—urinary bladder cancer	0.0341	0.0479	CbGbCtD
Brompheniramine—CHRM3—ureter—urinary bladder cancer	0.0303	0.183	CbGeAlD
Brompheniramine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0218	0.132	CbGeAlD
Brompheniramine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0209	0.0294	CbGbCtD
Brompheniramine—CYP3A4—Etoposide—urinary bladder cancer	0.0195	0.0274	CbGbCtD
Brompheniramine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0133	0.0187	CbGbCtD
Brompheniramine—CYP2C19—urine—urinary bladder cancer	0.00915	0.0554	CbGeAlD
Brompheniramine—CYP2C9—urine—urinary bladder cancer	0.00709	0.0429	CbGeAlD
Brompheniramine—CYP2E1—urine—urinary bladder cancer	0.00672	0.0407	CbGeAlD
Brompheniramine—CYP3A4—urine—urinary bladder cancer	0.00541	0.0327	CbGeAlD
Brompheniramine—CYP2D6—urine—urinary bladder cancer	0.00532	0.0322	CbGeAlD
Brompheniramine—CHRM5—epithelium—urinary bladder cancer	0.00464	0.0281	CbGeAlD
Brompheniramine—CHRM2—prostate gland—urinary bladder cancer	0.00434	0.0263	CbGeAlD
Brompheniramine—CHRM1—prostate gland—urinary bladder cancer	0.00395	0.0239	CbGeAlD
Brompheniramine—CHRM3—prostate gland—urinary bladder cancer	0.00353	0.0214	CbGeAlD
Brompheniramine—KCNH2—prostate gland—urinary bladder cancer	0.00313	0.019	CbGeAlD
Brompheniramine—KCNH2—seminal vesicle—urinary bladder cancer	0.00265	0.016	CbGeAlD
Brompheniramine—HRH1—prostate gland—urinary bladder cancer	0.00251	0.0152	CbGeAlD
Brompheniramine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.0025	0.0151	CbGeAlD
Brompheniramine—CYP2E1—prostate gland—urinary bladder cancer	0.00241	0.0146	CbGeAlD
Brompheniramine—CHRM3—renal system—urinary bladder cancer	0.00241	0.0146	CbGeAlD
Brompheniramine—CHRM3—urethra—urinary bladder cancer	0.00237	0.0143	CbGeAlD
Brompheniramine—CHRM1—female reproductive system—urinary bladder cancer	0.00216	0.013	CbGeAlD
Brompheniramine—KCNH2—renal system—urinary bladder cancer	0.00214	0.0129	CbGeAlD
Brompheniramine—KCNH2—urethra—urinary bladder cancer	0.0021	0.0127	CbGeAlD
Brompheniramine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00204	0.0124	CbGeAlD
Brompheniramine—CYP2C8—renal system—urinary bladder cancer	0.00195	0.0118	CbGeAlD
Brompheniramine—CHRM3—female reproductive system—urinary bladder cancer	0.00193	0.0117	CbGeAlD
Brompheniramine—HRH1—epithelium—urinary bladder cancer	0.00185	0.0112	CbGeAlD
Brompheniramine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00178	0.0108	CbGeAlD
Brompheniramine—CYP2B6—renal system—urinary bladder cancer	0.00175	0.0106	CbGeAlD
Brompheniramine—KCNH2—female reproductive system—urinary bladder cancer	0.00171	0.0103	CbGeAlD
Brompheniramine—HRH1—urethra—urinary bladder cancer	0.00168	0.0102	CbGeAlD
Brompheniramine—CYP2E1—renal system—urinary bladder cancer	0.00164	0.00995	CbGeAlD
Brompheniramine—CYP2C19—vagina—urinary bladder cancer	0.00162	0.00981	CbGeAlD
Brompheniramine—CYP2E1—urethra—urinary bladder cancer	0.00162	0.00978	CbGeAlD
Brompheniramine—CYP2C8—female reproductive system—urinary bladder cancer	0.00156	0.00947	CbGeAlD
Brompheniramine—KCNH2—vagina—urinary bladder cancer	0.00155	0.00936	CbGeAlD
Brompheniramine—CYP2C8—vagina—urinary bladder cancer	0.00142	0.00856	CbGeAlD
Brompheniramine—CYP2B6—female reproductive system—urinary bladder cancer	0.0014	0.00849	CbGeAlD
Brompheniramine—CYP2C9—female reproductive system—urinary bladder cancer	0.00139	0.00841	CbGeAlD
Brompheniramine—HRH1—female reproductive system—urinary bladder cancer	0.00137	0.0083	CbGeAlD
Brompheniramine—CYP3A4—renal system—urinary bladder cancer	0.00132	0.00801	CbGeAlD
Brompheniramine—CYP2E1—female reproductive system—urinary bladder cancer	0.00132	0.00797	CbGeAlD
Brompheniramine—CYP2D6—renal system—urinary bladder cancer	0.0013	0.00788	CbGeAlD
Brompheniramine—CYP2B6—vagina—urinary bladder cancer	0.00127	0.00768	CbGeAlD
Brompheniramine—HRH1—vagina—urinary bladder cancer	0.00124	0.0075	CbGeAlD
Brompheniramine—CYP3A4—female reproductive system—urinary bladder cancer	0.00106	0.00641	CbGeAlD
Brompheniramine—CYP2D6—female reproductive system—urinary bladder cancer	0.00104	0.00631	CbGeAlD
Brompheniramine—KCNH2—lymph node—urinary bladder cancer	0.001	0.00605	CbGeAlD
Brompheniramine—HRH1—lymph node—urinary bladder cancer	0.000802	0.00485	CbGeAlD
Brompheniramine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.31e-05	0.000186	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.31e-05	0.000186	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.3e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IGF1—urinary bladder cancer	2.29e-05	0.000185	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.28e-05	0.000184	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.28e-05	0.000184	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.28e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—urinary bladder cancer	2.28e-05	0.000184	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NCOR1—urinary bladder cancer	2.28e-05	0.000184	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NCOR1—urinary bladder cancer	2.27e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NCOR1—urinary bladder cancer	2.26e-05	0.000183	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	2.24e-05	0.000181	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.23e-05	0.00018	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.23e-05	0.00018	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CREBBP—urinary bladder cancer	2.22e-05	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—urinary bladder cancer	2.22e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—urinary bladder cancer	2.21e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—urinary bladder cancer	2.2e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IGF1—urinary bladder cancer	2.19e-05	0.000177	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.19e-05	0.000177	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.18e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	2.18e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—urinary bladder cancer	2.18e-05	0.000176	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.18e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—KRAS—urinary bladder cancer	2.15e-05	0.000174	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.14e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.14e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.14e-05	0.000173	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.11e-05	0.00017	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.11e-05	0.00017	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.1e-05	0.00017	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RHOA—urinary bladder cancer	2.1e-05	0.000169	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—urinary bladder cancer	2.09e-05	0.000169	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.09e-05	0.000169	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.07e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	2.07e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—KRAS—urinary bladder cancer	2.06e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.06e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.03e-05	0.000164	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.02e-05	0.000163	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—urinary bladder cancer	2.01e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RHOA—urinary bladder cancer	2.01e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—urinary bladder cancer	2.01e-05	0.000162	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TERT—urinary bladder cancer	2.01e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—urinary bladder cancer	2e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TERT—urinary bladder cancer	2e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TERT—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.99e-05	0.000161	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	1.98e-05	0.00016	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	1.97e-05	0.000159	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.97e-05	0.000159	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.97e-05	0.000159	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ERBB2—urinary bladder cancer	1.94e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PPARG—urinary bladder cancer	1.94e-05	0.000157	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000155	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.89e-05	0.000152	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CREBBP—urinary bladder cancer	1.86e-05	0.00015	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ERBB2—urinary bladder cancer	1.86e-05	0.00015	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.85e-05	0.00015	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-05	0.000149	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.85e-05	0.000149	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGFR3—urinary bladder cancer	1.84e-05	0.000149	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—urinary bladder cancer	1.84e-05	0.000149	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGFR3—urinary bladder cancer	1.84e-05	0.000148	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGFR3—urinary bladder cancer	1.83e-05	0.000148	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—HRAS—urinary bladder cancer	1.83e-05	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	1.81e-05	0.000146	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ESR1—urinary bladder cancer	1.79e-05	0.000144	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ESR1—urinary bladder cancer	1.78e-05	0.000144	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000144	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ESR1—urinary bladder cancer	1.78e-05	0.000143	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.77e-05	0.000143	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—urinary bladder cancer	1.76e-05	0.000142	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HRAS—urinary bladder cancer	1.75e-05	0.000141	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.75e-05	0.000141	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.74e-05	0.000141	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCND1—urinary bladder cancer	1.71e-05	0.000138	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.71e-05	0.000138	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.71e-05	0.000138	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.69e-05	0.000136	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—urinary bladder cancer	1.68e-05	0.000136	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.67e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—urinary bladder cancer	1.66e-05	0.000134	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.66e-05	0.000134	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CDKN1A—urinary bladder cancer	1.66e-05	0.000134	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTEN—urinary bladder cancer	1.66e-05	0.000134	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.000133	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCND1—urinary bladder cancer	1.64e-05	0.000133	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.64e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.63e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.62e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.62e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.62e-05	0.000131	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	0.000129	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	0.000129	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.6e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—urinary bladder cancer	1.59e-05	0.000129	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CDKN1A—urinary bladder cancer	1.59e-05	0.000128	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTEN—urinary bladder cancer	1.58e-05	0.000128	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EP300—urinary bladder cancer	1.58e-05	0.000127	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.57e-05	0.000127	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	1.57e-05	0.000127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CREBBP—urinary bladder cancer	1.56e-05	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CREBBP—urinary bladder cancer	1.56e-05	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000125	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.55e-05	0.000125	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	1.55e-05	0.000125	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1—urinary bladder cancer	1.54e-05	0.000125	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	1.54e-05	0.000125	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—urinary bladder cancer	1.54e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SRC—urinary bladder cancer	1.53e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—urinary bladder cancer	1.53e-05	0.000124	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—urinary bladder cancer	1.53e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	1.52e-05	0.000123	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.52e-05	0.000123	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	1.52e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EP300—urinary bladder cancer	1.51e-05	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.51e-05	0.000122	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SRC—urinary bladder cancer	1.47e-05	0.000119	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	1.46e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	1.45e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—urinary bladder cancer	1.45e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	1.43e-05	0.000116	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.43e-05	0.000115	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	1.42e-05	0.000114	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.42e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	1.41e-05	0.000114	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.41e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RHOA—urinary bladder cancer	1.41e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	1.4e-05	0.000113	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.38e-05	0.000111	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—urinary bladder cancer	1.38e-05	0.000111	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.36e-05	0.00011	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—urinary bladder cancer	1.35e-05	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—urinary bladder cancer	1.33e-05	0.000107	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	1.32e-05	0.000106	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	1.31e-05	0.000106	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	1.31e-05	0.000106	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	1.3e-05	0.000105	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.29e-05	0.000104	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	1.27e-05	0.000103	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—EP300—urinary bladder cancer	1.27e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.26e-05	0.000102	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	1.25e-05	0.0001	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	1.24e-05	0.0001	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	1.24e-05	9.99e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	1.24e-05	9.98e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	1.23e-05	9.95e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	1.23e-05	9.92e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	1.23e-05	9.89e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	1.22e-05	9.82e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	1.22e-05	9.82e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	9.77e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	1.19e-05	9.6e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	1.19e-05	9.57e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	1.18e-05	9.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	1.17e-05	9.45e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	1.16e-05	9.36e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.16e-05	9.36e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	1.16e-05	9.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	1.15e-05	9.3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.15e-05	9.29e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.15e-05	9.28e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.14e-05	9.24e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	1.14e-05	9.21e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	1.13e-05	9.12e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	1.13e-05	9.09e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	1.12e-05	9.06e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.12e-05	9.06e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.12e-05	9.05e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	1.12e-05	9.04e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	1.12e-05	9.03e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.12e-05	9.03e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	1.12e-05	9.01e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.11e-05	9e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	8.99e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	1.11e-05	8.98e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.11e-05	8.97e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	1.11e-05	8.94e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	8.91e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.1e-05	8.91e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	1.1e-05	8.89e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.09e-05	8.81e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	1.08e-05	8.73e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	1.08e-05	8.72e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.07e-05	8.64e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.07e-05	8.63e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	1.07e-05	8.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	1.06e-05	8.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	1.06e-05	8.56e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	8.54e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	8.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	1.05e-05	8.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	1.04e-05	8.38e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	1.03e-05	8.33e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	1.02e-05	8.25e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.01e-05	8.18e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.95e-06	8.03e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.92e-06	8e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	9.69e-06	7.82e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.35e-06	7.55e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	9.3e-06	7.51e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	9.27e-06	7.49e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	9.24e-06	7.46e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—EP300—urinary bladder cancer	9.24e-06	7.46e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	9.16e-06	7.39e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	9.12e-06	7.36e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	9.1e-06	7.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	9.07e-06	7.32e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.04e-06	7.3e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	9.04e-06	7.3e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	8.95e-06	7.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	8.65e-06	6.98e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	8.6e-06	6.94e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	8.57e-06	6.92e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	8.54e-06	6.89e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	8.46e-06	6.83e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—EP300—urinary bladder cancer	8.25e-06	6.66e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.95e-06	6.42e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	7.89e-06	6.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	7.64e-06	6.17e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	7.62e-06	6.15e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	7.59e-06	6.13e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.59e-06	6.12e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.58e-06	6.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—EP300—urinary bladder cancer	7.52e-06	6.07e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	7.52e-06	6.07e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	7.31e-06	5.9e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	7.28e-06	5.88e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.28e-06	5.88e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	7.26e-06	5.86e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	7.19e-06	5.8e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.96e-06	4.81e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.2e-06	4.2e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.96e-06	4e-05	CbGpPWpGaD
